Skip to main content

Table 4 Distribution of antimicrobial susceptibility patterns for gram negative isolates

From: Sepsis in cancer patients residing in Zimbabwe: spectrum of bacterial and fungal aetiologies and their antimicrobial susceptibility patterns

Bacterial isolates

N

AMP

PTZ

CXM

CRO

CAZ

CEF

FOX

GM

AK

CIP

LEV

MEM

COT

E. coli

8

1

7

2

2

2

4

7

2

8

2

2

8

0

K. pneumoniae

7

0

4

2

2

2

4

6

3

7

3

4

7

1

E. intermedium

1

0

1

0

0

0

1

0

1

0

1

1

1

0

S. odorifera

1

0

0

0

0

0

0

0

0

0

0

1

0

0

S. enteritidis

1

0

1

0

1

1

1

0

0

0

1

1

1

0

Acinetobacter sp.

1

0

0

0

1

1

1

0

0

1

0

0

1

0

P. aeruginosa

1

–

1

–

0

1

1

–

1

1

1

1

1

0

H. alvei

1

0

1

0

0

0

1

1

1

1

1

1

1

0

Total n (%)

21 (100)

1(4.8)

15(71.4)

4(19.0)

6(28.6)

7(33.3)

13(61.9)

14(66.7)

8(38.1)

18(85.7)

9(42.9)

11(52.4)

20(95.2)

1(4.8)

  1. Notes: AMP Ampicillin, PTZ Piperacillin-tazobactam, CRO Ceftriaxone, CAZ Ceftazidime, CXM Cefuroxime, CEF Cefepime, FOX Cefoxitin, GM Gentamicin, AK Amikacin, CIP ciprofloxacin, LEV Levofloxacin, COT Trimethoprim-sulfamethoxazole, MEM Meropenem; N Number; (−), not tested, (0), zero sensitive isolates